Literature DB >> 23583611

Increased susceptibility to acetylcholine in the entorhinal cortex of pilocarpine-treated rats involves alterations in KCNQ channels.

Anna Maslarova1, Seda Salar, Ezequiel Lapilover, Alon Friedman, Rüdiger W Veh, Uwe Heinemann.   

Abstract

In models of temporal lobe epilepsy, in-vitro exposure of the entorhinal cortex (EC) to low concentrations of acetylcholine (ACh) induces muscarinic-dependent seizure-like events. Potassium channels from the KCNQ/Kv7 family, which close upon activation of muscarinic receptors, are mutated in several epileptic syndromes such as benign familial neonatal convulsions (KCNQ2/KCNQ3) and sudden unexplained death in epilepsy (KCNQ1). Therefore, we tested the hypothesis whether the ictogenic effect of ACh involves alterations of KCNQ channels. In horizontal temporo-hippocampal slices from pilocarpine-treated chronically epileptic rats, field potential recordings of epileptiform activity were performed in response to the application of ACh, the KCNQ blocker linopirdine, and KCNQ agonists. In the EC of control rats, ACh (20 and 50 μM) induced nested fast activity in the range of 15-20 Hz riding on <1 Hz slow oscillations. By contrast, in slices from pilocarpine-treated rats, 5 μM ACh was sufficient to induce interictal discharges that frequently transformed to epileptiform events at 20 μM ACh. While the non-specific KCNQ/Kv7 channel blocker linopirdine (20 and 50 μM) had no effect in control animals, in slices from epileptic rats it induced interictal discharges or seizure-like events. These could be blocked by the unspecific KCNQ/Kv7 agonist retigabine and attenuated by the Kv7.1 agonist L364-373. Immunohistochemistry revealed reduced expression of KCNQ2 and KCNQ3 in the EC and of KCNQ3-positive dendrites in the subiculum of epileptic rats. These results indicate that channels of the KCNQ family are key regulators of seizure susceptibility and their decreased availability in the epileptic tissue may reduce seizure threshold and contribute to ictogenesis.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23583611     DOI: 10.1016/j.nbd.2013.02.016

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  10 in total

1.  Conditional deletions of epilepsy-associated KCNQ2 and KCNQ3 channels from cerebral cortex cause differential effects on neuronal excitability.

Authors:  Heun Soh; Rima Pant; Joseph J LoTurco; Anastasios V Tzingounis
Journal:  J Neurosci       Date:  2014-04-09       Impact factor: 6.167

2.  Recurrent epileptiform discharges in the medial entorhinal cortex of kainate-treated rats are differentially sensitive to antiseizure drugs.

Authors:  Peter J West; Gerald W Saunders; Peggy Billingsley; Misty D Smith; H Steve White; Cameron S Metcalf; Karen S Wilcox
Journal:  Epilepsia       Date:  2018-10-17       Impact factor: 5.864

Review 3.  Voltage-gated potassium channels at the crossroads of neuronal function, ischemic tolerance, and neurodegeneration.

Authors:  Niyathi Hegde Shah; Elias Aizenman
Journal:  Transl Stroke Res       Date:  2013-11-19       Impact factor: 6.829

Review 4.  Potassium Channels in Epilepsy.

Authors:  Rüdiger Köhling; Jakob Wolfart
Journal:  Cold Spring Harb Perspect Med       Date:  2016-05-02       Impact factor: 6.915

5.  Dynamic changes in murine forebrain miR-211 expression associate with cholinergic imbalances and epileptiform activity.

Authors:  Uriya Bekenstein; Nibha Mishra; Dan Z Milikovsky; Geula Hanin; Daniel Zelig; Liron Sheintuch; Amit Berson; David S Greenberg; Alon Friedman; Hermona Soreq
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-05       Impact factor: 11.205

6.  The transcription factor NRSF contributes to epileptogenesis by selective repression of a subset of target genes.

Authors:  Shawn McClelland; Gary P Brennan; Celine Dubé; Seeta Rajpara; Shruti Iyer; Cristina Richichi; Christophe Bernard; Tallie Z Baram
Journal:  Elife       Date:  2014-08-12       Impact factor: 8.140

7.  PLPP/CIN-mediated NEDD4-2 S448 dephosphorylation regulates neuronal excitability via GluA1 ubiquitination.

Authors:  Ji-Eun Kim; Duk-Shin Lee; Min Ju Kim; Tae-Cheon Kang
Journal:  Cell Death Dis       Date:  2019-07-18       Impact factor: 8.469

Review 8.  The current approach of the Epilepsy Therapy Screening Program contract site for identifying improved therapies for the treatment of pharmacoresistant seizures in epilepsy.

Authors:  Karen S Wilcox; Peter J West; Cameron S Metcalf
Journal:  Neuropharmacology       Date:  2019-11-30       Impact factor: 5.273

9.  Applicability of hiPSC-Derived Neuronal Cocultures and Rodent Primary Cortical Cultures for In Vitro Seizure Liability Assessment.

Authors:  Anke M Tukker; Fiona M J Wijnolts; Aart de Groot; Remco H S Westerink
Journal:  Toxicol Sci       Date:  2020-11-01       Impact factor: 4.849

Review 10.  Novel test strategies for in vitro seizure liability assessment.

Authors:  Anke M Tukker; Remco H S Westerink
Journal:  Expert Opin Drug Metab Toxicol       Date:  2021-02-17       Impact factor: 4.481

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.